Company news

NeoGenomics, Inc. news in 2026

NeoGenomics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

NeoGenomics Reports Third Quarter 2026 Results

October 28, 2026

NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology

October 15, 2026

NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026

October 14, 2026

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

October 5, 2026

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 1, 2026

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring

August 26, 2026

NeoGenomics Reports Second Quarter 2026 Results

July 28, 2026

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

July 20, 2026

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

July 9, 2026

NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

July 7, 2026

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

June 25, 2026

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

June 17, 2026

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes

June 15, 2026

Neo4j Acquires GraphAware to Launch Intelligence Analysis Alternative to Palantir Gotham

June 3, 2026

NeoGenomics to Present New Research at ASCO Annual Meeting 2026

May 26, 2026

NeoGenomics Reports First Quarter 2026 Results

April 28, 2026

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration

April 22, 2026

NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026

April 7, 2026

NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

March 15, 2026

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

February 25, 2026

NeoGenomics Reports Fourth Quarter and Full Year 2025 Results

February 17, 2026

NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection

February 12, 2026

NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

January 27, 2026

NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

January 12, 2026

NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 4, 2026

Calls in 2026

Decks in 2026